[Skip to Content]
Sign In
Individual Sign In
Create an Account
Institutional Sign In
OpenAthens Shibboleth
[Skip to Content Landing]
Views 157
Citations 0
Correction
June 24, 2020

Additional Conflict of Interest Disclosures

JAMA Cardiol. Published online June 24, 2020. doi:10.1001/jamacardio.2020.2577

In the Research Letter “Assessment of QT Intervals in a Case Series of Patients With Coronavirus Disease 2019 (COVID-19) Infection Treated With Hydroxychloroquine Alone or in Combination With Azithromycin in an Intensive Care Unit,”1 published online on May 1, 2020, in JAMA Cardiology, conflict of interest disclosures were omitted for 2 authors. The conflict of interest disclosure statement should have included the following: “Dr Bessière reports grants and personal fees from Abbott, Boston Scientific, Medtronic, Biosense, and Volta Medical outside the submitted work. Dr Chevalier reports grants from Abbott, Boston Scientific, and Medtronic outside the submitted work. No other disclosures were reported.” The Article Information section has been corrected to include this information.

References
1.
Bessière  F, Roccia  HPA, Deliniere  A,  et al.  Assessment of QT intervals in a case series of patients with coronavirus disease 2019 (COVID-2019) infection treated with hydroxychloroquine alone or in combination with azithromycin in an intensive care unit.   JAMA Cardiol. Published online May 1, 2020. doi:10.1001/jamacardio.2020.1787Google Scholar
×